We are looking to collaborate with licensed processors/distributors of Cannabis and Cannabis Products for Medical Purposes.
CanaQuest Medical Corp is engaged in the development of unique health products and nutraceuticals that utilize hemp, cannabis, food grade botanicals and algae oil extracts. The Company has engaged two Canadian universities to provide research into the use of these extracts and cannabis formulations, which we are using to develop products that combine the significant health benefits.
Our research is focused on the use of cannabis in the context of cancer and the use of cannabis derivatives for the development of our novel pharmacotherapies for mental health.
We have human trial programs with two reputable clinics to initiate trials, based on the successful results from research and animal pre-clinical data from the lab of Dr. Steven Laviolette, Western University. The first trial will focus on mental health (anxiety, depression) and the second one will focus on pain management (alternative to opioids).
We are looking to secure a partner/collaborator to:
Import cannabis flower, cannabis oil extracts and/or formulated and packaged cannabis products for distribution in their respective country (medical purposes only)
Two initial formulations include:
- Novel THC formulation – non-psychoactive
- Novel CBD formulation – superior to existing CBDs
Included in our formulations is a technology that greatly increases the bioavailability of edibles.
Our products will be formulated and packaged for sale and distribution by our Licensed Partners in respective countries to complement our agreement with JMCC, Jamaica (GMP, EUGMP approved facilities).
We welcome having an opportunity to discuss collaboration for the USA, Canadian and Global markets.
Please feel free to contact the President of CanaQuest directly using the contact info below.
Paul Ramsay, President
CanaQuest Medical Corp